Physitrack 향후 성장

Future 기준 점검 1/6

Physitrack의 수익이 증가할 것으로 예상됨입니다.

핵심 정보

n/a

이익 성장률

n/a

EPS 성장률

Healthcare Services 이익 성장	19.5%
매출 성장률	6.6%
향후 자기자본이익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	26 Nov 2025

최근 향후 성장 업데이트

Recent updates

Subdued Growth No Barrier To Physitrack PLC (STO:PTRK) With Shares Advancing 28%

Jun 20

Is Physitrack (STO:PTRK) A Risky Investment?

Jun 01

Physitrack PLC's (STO:PTRK) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 08

Physitrack PLC's (STO:PTRK) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Feb 06

Is Physitrack (STO:PTRK) A Risky Investment?

Feb 05

Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Nov 20

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Nov 13

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Nov 13

Investors Aren't Entirely Convinced By Physitrack PLC's (STO:PTRK) Revenues

Jun 15

Physitrack (STO:PTRK) Is Doing The Right Things To Multiply Its Share Price

May 09

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

Apr 10

Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Feb 29

Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Oct 12

Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Aug 18

Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Jan 29

Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Oct 29

이익 및 매출 성장 예측

OM:PTRK - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
12/31/2027	18	N/A	N/A	N/A	1
12/31/2026	15	N/A	N/A	6	1
12/31/2025	14	N/A	N/A	2	1
9/30/2025	16	-6	1	4	N/A
6/30/2025	16	-6	1	4	N/A
3/31/2025	16	-7	0	3	N/A
12/31/2024	16	-6	0	3	N/A
9/30/2024	14	2	0	3	N/A
6/30/2024	14	2	0	3	N/A
3/31/2024	15	3	0	3	N/A
12/31/2023	15	3	-1	3	N/A
9/30/2023	15	0	-2	2	N/A
6/30/2023	14	0	-2	2	N/A
3/31/2023	14	0	-3	2	N/A
12/31/2022	13	0	-3	1	N/A
9/30/2022	11	0	-3	1	N/A
6/30/2022	10	0	-3	0	N/A
3/31/2022	9	-1	-2	0	N/A
12/31/2021	8	-1	-1	1	N/A
11/30/2021	8	-1	-1	1	N/A
8/31/2021	6	-1	0	1	N/A
5/31/2021	5	1	1	2	N/A
2/28/2021	4	1	1	2	N/A
11/30/2020	3	1	1	2	N/A
11/30/2019	1	0	0	1	N/A
11/30/2018	1	0	N/A	N/A	N/A
11/30/2017	0	0	N/A	N/A	N/A
11/30/2016	0	0	N/A	N/A	N/A
11/30/2015	0	0	N/A	N/A	N/A

애널리스트 향후 성장 전망

수입 대 저축률: PTRK 의 예상 수익 증가율이 절약률(1.7%)보다 높은지 판단하기에는 데이터가 부족합니다.

수익 vs 시장: PTRK 의 수익이 Swedish 시장보다 빠르게 성장할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

고성장 수익: PTRK 의 수익이 향후 3년 동안 상당히 증가할 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

수익 대 시장: PTRK 의 수익(연간 6.6%)이 Swedish 시장(연간 3.8%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: PTRK 의 수익(연간 6.6%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: PTRK의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/12/07 03:12
종가	2025/12/05 00:00
수익	2025/09/30
연간 수익	2024/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Physitrack PLC는 3명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Rebecka Gärderup	ABG Sundal Collier Sponsored
Joachim Gunell	DNB Carnegie
Jessica Grunewald	Redeye

Physitrack 향후 성장

Future 기준 점검 1/6

핵심 정보

최근 향후 성장 업데이트

Consensus EPS estimates upgraded to €0.025 loss

Physitrack PLC Provides Earnings Guidance

Recent updates

Is Physitrack (STO:PTRK) A Risky Investment?

Physitrack's (STO:PTRK) Returns On Capital Not Reflecting Well On The Business

Third quarter 2025 earnings released: €0.02 loss per share (vs €0.023 loss in 3Q 2024)

Physitrack PLC's (STO:PTRK) 32% Price Boost Is Out Of Tune With Revenues

Second quarter 2025 earnings released: €0.01 loss per share (vs €0.029 loss in 2Q 2024)

Subdued Growth No Barrier To Physitrack PLC (STO:PTRK) With Shares Advancing 28%

Is Physitrack (STO:PTRK) A Risky Investment?

First quarter 2025 earnings released: €0.03 loss per share (vs €0.007 loss in 1Q 2024)

Physitrack PLC, Annual General Meeting, Jun 27, 2025

Physitrack PLC's (STO:PTRK) 26% Dip In Price Shows Sentiment Is Matching Revenues

Full year 2024 earnings released: €0.40 loss per share (vs €0.17 profit in FY 2023)

Management of Wellnow Group acquired Wellnow Group GmbH from Physitrack PLC (OM:PTRK) €0.300001 million.

Physitrack plc Announces Chief Financial Officer Changes

Physitrack Plc Launches Enhanced PhysiAssistant App with New Filming & Exercise Upload Feature

Full year 2024 earnings released: €0.40 loss per share (vs €0.20 profit in FY 2023)

Investor sentiment improves as stock rises 31%

Physitrack PLC's (STO:PTRK) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Is Physitrack (STO:PTRK) A Risky Investment?

Investor sentiment improves as stock rises 17%

Physitrack PLC to Report Q4, 2025 Results on Feb 28, 2026

Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Third quarter 2024 earnings released: €0.02 loss per share (vs €0.015 loss in 3Q 2023)

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 22%

Chairman & Senior Independent Director recently bought kr51k worth of stock

Second quarter 2024 earnings released: €0.029 loss per share (vs €0.015 loss in 2Q 2023)

Investor sentiment improves as stock rises 16%

Investors Aren't Entirely Convinced By Physitrack PLC's (STO:PTRK) Revenues

Chairman & Senior Independent Director recently bought kr57k worth of stock

First quarter 2024 earnings released: €0.01 loss per share (vs €0.004 loss in 1Q 2023)

Investor sentiment improves as stock rises 16%

Physitrack (STO:PTRK) Is Doing The Right Things To Multiply Its Share Price

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

New minor risk - Earnings quality

Investor sentiment deteriorates as stock falls 18%

Full year 2023 earnings released: EPS: €0.20 (vs €0.006 in FY 2022)

Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Physitrack PLC, Annual General Meeting, May 03, 2024

Physitrack PLC to Report Q4, 2024 Results on Feb 28, 2025

New minor risk - Share price stability

Third quarter 2023 earnings released: €0.01 loss per share (vs €0.001 profit in 3Q 2022)

Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Second quarter 2023 earnings released: €0.015 loss per share (vs €0.026 loss in 2Q 2022)

New minor risk - Share price stability

Physitrack plc Announces Board Changes

Physitrack PLC Announces Appointment of Jack Goodwin as Head of People

Physitrack PLC Approves Election of Anne-Sophie D'andlau as Director

First quarter 2023 earnings released

Independent Non-Executive Director recently bought kr56k worth of stock

Consensus EPS estimates upgraded to €0.025 loss

Full year 2022 earnings released: EPS: €0.01 (vs €0.06 loss in FY 2021)

Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Physitrack PLC Appoints Nick McClelland to Take on A New Role as Chief Growth Officer

High number of new and inexperienced directors

Physitrack PLC Announces the Appoints Anne-Sophie d'Andlau as Board Member

Third quarter 2022 earnings released: EPS: €0.001 (vs €0.07 loss in 3Q 2021)

Physitrack PLC to Report Q2, 2023 Results on Aug 15, 2023

Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Henrik Molin, Chief Executive Officer and Co-founder of Physitrack PLC acquired an additional 4.3% stake in Physitrack PLC (OM : PTRK) from Nathan Skwortsow, co-founder of Physitrack PLC for €1 million.

Second quarter 2022 earnings released: €0.02 loss per share (vs €0.011 loss in 2Q 2021)

Physitrack plc Recruits Announces Management Changes

Chief Operating Officer recently bought kr56k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Physitrack PLC (OM:PTRK) acquired Champion Health Ltd from Harry Bliss and Ricky Bailey for £10.4 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Chief Financial Officer recently bought kr62k worth of stock

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Full year 2021 earnings: EPS exceeds analyst expectations

Physitrack PLC Provides Earnings Guidance

Investor sentiment improved over the past week